Xilong Scientific's future revenue performance is expected t...

Xilong Scientific's future revenue performance is expected to dwindle, keeping the P/S suppressed. Its weak share price has pulled its P/S back below other Chemicals companies. Investors expect limited growth rates to continue, willing to pay a reduced amount for the stock. Unless medium-term conditions improve, they will continue to form a barrier for the share price.